www.fdanews.com/articles/122247-fair-balance-adverse-event-guidance-needed-for-social-media-use-industry-says
Fair Balance, Adverse Event Guidance Needed for Social Media Use, Industry Says
November 16, 2009
Drugmakers are telling
the FDA that they need specific guidance on presenting balanced risk-benefit information for products on social media such as Twitter. Drugmakers, marketing
agencies and patient advocacy groups also asked for agency guidance on when social media monitoring should trigger adverse event reports at the agency’s
public hearing on social media.
Washington Drug Letter
Washington Drug Letter